As a strike looms, teachers say they are underpaid for the growing workload they bear, and burning out from trying to meet ...

A new report by the BPI outlines an alarming drop in British life sciences investment as companies increasingly turn ...

As a South African executive, you've likely scrutinised your compensation package and pondered: does this truly reflect the ...

Committee for Medicinal Products for Human Use (CHMP) approved an update to Novo Nordisk A/S‘ (NYSE:NVO) Rybelsus (oral ...

Hispanic patients starting hemodialysis in the US are less likely to receive predialysis nephrology care and, consequently, ...

Taking a natural income, we believe, enables a longer-term approach and allows for a bit more capital volatility with your ...

HHS has a tremendous opportunity to ensure that both government and private insurers are paying for oncology treatments ...

Semaglutide treatment was not associated with an increased risk for eye disorders or diabetic retinopathy but may increase ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...

The WHO approves lenacapavir every six months as a new step in HIV prevention, simplifying diagnoses and expanding ...

Discover IDU ETF's risk-spreading strategy, sector correlation, yield, and diversification. Compare IDU to XLU, VPU, UTES & ...

The global collaboration provides an integrated translational biology platform to accelerate the development of novel ...